Christel Herold‐Mende
- Genetics top 0.05%
- Glioma Diagnosis and Treatment 114
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 33
- MicroRNA in disease regulation 15
- Oncology top 0.5%
- Cancer Cells and Metastasis 23
- Immunology top 1%
- Immunotherapy and Immune Responses 20
- Immune cells in cancer 17
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 17
-
- Meningioma and schwannoma management 25
- Co-authors
- Andreas von DeimlingAndreas UnterbergDavid CapperBenito CamposChristian HartmannWolfgang WickRezvan AhmadiGuido Reifenberger
- Cited by
- GeneticsCancer ResearchOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Christel Herold‐Mende
300 papers receiving 14.2k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Genetics 5.6k
- Cancer Research 3.6k
- Oncology 4.3k
- Immunology 2.0k
- Molecular Biology 6.3k
Countries citing papers authored by Christel Herold‐Mende
This map shows the geographic impact of Christel Herold‐Mende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christel Herold‐Mende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christel Herold‐Mende more than expected).
Fields of papers citing papers by Christel Herold‐Mende
This network shows the impact of papers produced by Christel Herold‐Mende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christel Herold‐Mende. The network helps show where Christel Herold‐Mende may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christel Herold‐Mende, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 23 | |
| 10 | 2020 | 27 | |
| 11 | 2019 | 26 | |
| 12 | 2019 | 22 | |
| 13 | 2018 | 22 | |
| 14 | 2018 | 10 | |
| 15 | 2017 | 45 | |
| 16 | 2013 | 100 | |
| 17 | 2011 | 272 | |
| 18 | 2010 | 251 | |
| 19 | 2009 | 150 | |
| 20 | [Significance of aberrant p53 protein in head-neck tumors and its effect on proliferation and differentiation]. | 1993 | 4 |
About Christel Herold‐Mende
Christel Herold‐Mende is a scholar working on Genetics, Cancer Research and Oncology, having authored 313 papers that have together received 14.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (114 papers), Cancer, Hypoxia, and Metabolism (33 papers), Meningioma and schwannoma management (25 papers), Cancer Cells and Metastasis (23 papers), Immunotherapy and Immune Responses (20 papers), Epigenetics and DNA Methylation (17 papers), Immune cells in cancer (17 papers) and MicroRNA in disease regulation (15 papers). The work is most often cited by research in Genetics (5.6k citations), Cancer Research (3.6k citations) and Oncology (4.3k citations). Christel Herold‐Mende has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas von Deimling, Andreas Unterberg, David Capper, Benito Campos, Christian Hartmann, Wolfgang Wick, Rezvan Ahmadi, Guido Reifenberger, Bernhard Radlwimmer and Gerhard Dyckhoff. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.